Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Lanzós, Andrés ^a,b,c   Carlevaro Fita, Joana ^a,b,c   Mularoni, Loris ^b   Reverter, Ferran ^a,b,c   Palumbo, Emilio ^a,b,c   Guigó, Roderic ^a,b,c   Johnson, Rory ^a,b,c,d  

^a BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER;

ALTERNATIVE RNA SPLICING; BIOLOGY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; GENOMICS; HUMAN; HUMAN GENOME; MUTATION; NEOPLASM; ONCOGENE; OPEN READING FRAME; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; BIOMARKERS, TUMOR; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HUMANS; MUTATION; NEOPLASMS; ONCOGENES; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING;

EID: 85010917065     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41544     Document Type: Article

References (53)

1. Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nature genetics 45, 1113-1120, doi: 10.1038/ng.2764 (2013).
2. Hudson, T. J. et al. International network of cancer genome projects. Nature 464, 993-998, doi: 10.1038/nature08987 (2010).
3. Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA biology 9, 703-719, doi: 10.4161/ rna.20481 (2012).
4. Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome research 22, 1775-1789, doi: 10.1101/gr.132159.111 (2012).
5. Ulitsky, I. & Bartel, D. P. lincRNAs: genomics, evolution, and mechanisms. Cell 154, 26-46, doi: 10.1016/j.cell.2013.06.020 (2013).
6. Liu, S. J. et al. Single-cell analysis of long non-coding RNAs in the developing human neocortex. Genome biology 17, 67, doi: 10.1186/s13059-016-0932-1 (2016).
7. Hangauer, M. J., Vaughn, I. W. & McManus, M. T. Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs. PLoS genetics 9, e1003569, doi: 10.1371/journal.pgen.1003569 (2013).
8. Iyer, M. K. et al. The landscape of long noncoding RNAs in the human transcriptome. Nature genetics, doi: 10.1038/ng.3192 (2015).
9. Chen, G. et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic acids research 41, D983-986, doi: 10.1093/nar/gks1099 (2013).
10. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419, doi: 10.1016/j.cell.2010.06.040 (2010).
11. Gupta, R. A. et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071-1076, doi: 10.1038/nature08975 (2010).
12. Du, Z. et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nature structural & molecular biology 20, 908-913, doi: 10.1038/nsmb.2591 (2013).
13. Zheng, J. et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nature genetics 48, 747-757, doi: 10.1038/ng.3568 (2016).
14. Akrami, R. et al. Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification. PloS one 8, e80306, doi: 10.1371/journal.pone.0080306 (2013).
15. Leucci, E. et al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature 531, 518-522, doi: 10.1038/nature17161 (2016).
16. Gonzalez-Perez, A. & Lopez-Bigas, N. Functional impact bias reveals cancer drivers. Nucleic acids research 40, e169, doi: 10.1093/ nar/gks743 (2012).
17. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218, doi: 10.1038/nature12213 (2013).
18. Reimand, J., Wagih, O. & Bader, G. D. The mutational landscape of phosphorylation signaling in cancer. Scientific reports 3, 2651, doi: 10.1038/srep02651 (2013).
19. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74, doi: 10.1038/nature11247 (2012).
20. Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346, doi: 10.1038/nature10887 (2012).
21. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421, doi: 10.1038/nature12477 (2013).
22. Haerty, W. & Ponting, C. P. Unexpected selection to retain high GC content and splicing enhancers within exons of multiexonic lncRNA loci. RNA 21, 333-346, doi: 10.1261/rna.047324.114 (2015).
23. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251-263, doi: 10.1016/j.cell.2012.06.024 (2012).
24. Futreal, P. A. et al. A census of human cancer genes. Nature reviews. Cancer 4, 177-183, doi: 10.1038/nrc1299 (2004).
25. Xu, C., Ciampi, A. & Greenwood, C. M. Exploring the potential benefits of stratified false discovery rates for region-based testing of association with rare genetic variation. Frontiers in genetics 5, 11, doi: 10.3389/fgene.2014.00011 (2014).
26. Sun, L., Craiu, R. V., Paterson, A. D. & Bull, S. B. Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genetic epidemiology 30, 519-530, doi: 10.1002/gepi.20164 (2006).
27. Fujimoto, A. et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nature genetics 48, 500-509, doi: 10.1038/ng.3547 (2016).
28. Sanchez, Y. et al. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nature communications 5, 5812, doi: 10.1038/ncomms6812 (2014).
29. Yan, X. et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer cell 28, 529-540, doi: 10.1016/j.ccell.2015.09.006 (2015).
30. Tamborero, D. et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Scientific reports 3, 2650, doi: 10.1038/srep02650 (2013).
31. Liu, W. B. et al. ANKRD18A as a novel epigenetic regulation gene in lung cancer. Biochemical and biophysical research communications 429, 180-185, doi: 10.1016/j.bbrc.2012.10.116 (2012).
32. Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nature methods 10, 1081-1082, doi: 10.1038/nmeth.2642 (2013).
33. Matos, L. L. et al. The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms. PloS one 10, e0141139, doi: 10.1371/journal.pone.0141139 (2015).
34. Dong, W. et al. Inactivation of MYO5B promotes invasion and motility in gastric cancer cells. Digestive diseases and sciences 57, 1247-1252, doi: 10.1007/s10620-011-1989-z (2012).
35. Tamborero, D., Gonzalez-Perez, A. & Lopez-Bigas, N. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29, 2238-2244, doi: 10.1093/bioinformatics/btt395 (2013).
36. Marques, A. C. et al. Chromatin signatures at transcriptional start sites separate two equally populated yet distinct classes of intergenic long noncoding RNAs. Genome biology 14, R131, doi: 10.1186/gb-2013-14-11-r131 (2013).
37. Hezroni, H. et al. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. Cell reports 11, 1110-1122, doi: 10.1016/j.celrep.2015.04.023 (2015).
38. Furney, S. J., Higgins, D. G., Ouzounis, C. A. & Lopez-Bigas, N. Structural and functional properties of genes involved in human cancer. BMC genomics 7, 3, doi: 10.1186/1471-2164-7-3 (2006).
39. Criscione, S. W., Zhang, Y., Thompson, W., Sedivy, J. M. & Neretti, N. Transcriptional landscape of repetitive elements in normal and cancer human cells. BMC genomics 15, 583, doi: 10.1186/1471-2164-15-583 (2014).
40. Ferreira, P. G. et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome research 24, 212-226, doi: 10.1101/gr.152132.112 (2014).
41. Johnson, R. & Guigo, R. The RIDL hypothesis: transposable elements as functional domains of long noncoding RNAs. RNA 20, 959-976, doi: 10.1261/rna.044560.114 (2014).
42. Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature genetics 38, 813-818, doi: 10.1038/ng1810 (2006).
43. Zhang, X. et al. Identification of common genetic variants controlling transcript isoform variation in human whole blood. Nature genetics 47, 345-352, doi: 10.1038/ng.3220 (2015).
44. Sabarinathan, R. et al. RNAsnp: efficient detection of local RNA secondary structure changes induced by SNPs. Human mutation 34, 546-556, doi: 10.1002/humu.22273 (2013).
45. Halvorsen, M., Martin, J. S., Broadaway, S. & Laederach, A. Disease-associated mutations that alter the RNA structural ensemble. PLoS genetics 6, e1001074, doi: 10.1371/journal.pgen.1001074 (2010).
46. Alioto, T. S. et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nature communications 6, 10001, doi: 10.1038/ncomms10001 (2015).
47. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome research 22, 1760-1774, doi: 10.1101/gr.135350.111 (2012).
48. Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nature genetics 46, 573-582, doi: 10.1038/ng.2983 (2014).
49. Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic acids research 41, e74, doi: 10.1093/nar/gkt006 (2013).
50. Robinson, J. T. et al. Integrative genomics viewer. Nature biotechnology 29, 24-26, doi: 10.1038/nbt.1754 (2011).
51. Amaral, P. P., Clark, M. B., Gascoigne, D. K., Dinger, M. E. & Mattick, J. S. lncRNAdb: a reference database for long noncoding RNAs. Nucleic acids research 39, D146-151, doi: 10.1093/nar/gkq1138 (2011).
52. Knowles, D. G., Roder, M., Merkel, A. & Guigo, R. Grape RNA-Seq analysis pipeline environment. Bioinformatics 29, 614-621, doi: 10.1093/bioinformatics/btt016 (2013).
53. Chen, C. L. et al. Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes. Genome research 20, 447-457, doi: 10.1101/gr.098947.109 (2010).